Searched for
SAXAGLIPTIN TABLETS
Glenmark Pharma gets tentative USFDA nod for generic anti-diabetes tabletsGlenmark Pharmaceuticals on Wednesday said it has received tentative approval from the US health regulator for its generic Dapagliflozin an...29 Apr, 2020, 12.11 PM IST- USV in talks with Novartis to buy Jalra Trademark for Rs. 200 CroreMumbai-based drugmaker USV Pvt Ltd is in advanced discussions to acquire the trademark for antidiabetes drug Jalra from Novartis for a deal...09 Dec, 2019, 07.27 AM IST
- Glenmark gets USFDA's tentative nod for Saxagliptin tabletsAccording to IMS Health sales data for the 12-month period ending April 2017, the Onglyza tablets, 2.5 mg and 5 mg market achieved annual s...14 Jun, 2017, 12.18 PM IST
- India rejects compulsory license application of Lee Pharma against AstraZeneca’s SaxagliptinThe Indian Patent Office has rejected the application of Lee Pharma for a compulsory license on AstraZeneca’s anti-diabetes drug saxaglipti...21 Jan, 2016, 04.14 AM IST
- India rejects Lee Pharma’s compulsory licence pleaIndia has decided against giving the compulsory licence for Anglo-Swedish drugmaker AstraZeneca’s key antidiabetes compound Saxagliptin.18 Aug, 2015, 04.51 AM IST
- High Court rejects AstraZeneca’s diabetes drug pleaThe Delhi High Court has dismissed AstraZeneca’s plea to block Hyderabadbased Lee Pharma from making copies of its anti-diabetes drug Ongly...30 Jul, 2015, 04.39 AM IST
- Lee Pharma wants licence for AstraZeneca's diabetes drugLee Pharma filed the application on June 29 to make a generic version of the patented drug, marketed as Onglyza, under Section 84 of the Pa...06 Jul, 2015, 10.58 AM IST
Load More
